Methylphenidate Hydrochloride Tablet, Extended Release shortage (US): status and presentations
Shortage United States · first listed 26 July 2023 · updated 15 October 2026
| Dosage form | Tablet |
|---|---|
| Therapy area | Psychiatry |
| Presentations | 6 unavailable, 9 limited, 19 available |
| Source | US FDA Drug Shortage Database (openFDA), checked 19 October 2026 |
Presentations affected
- Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg — Unavailable
- Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg — Unavailable
- Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg — Unavailable
- Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg — Unavailable
- Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg — Limited Availability
- Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg — Limited Availability
- Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg — Limited Availability
- Concerta, Tablet, Extended Release, 18 mg — Available
- Concerta, Tablet, Extended Release, 27 mg — Available
- Concerta, Tablet, Extended Release, 36 mg — Available
- Concerta, Tablet, Extended Release, 54 mg — Available
- Relexxii, Tablet, Extended Release, 18 mg — Available
- Relexxii, Tablet, Extended Release, 27 mg — Available
- Relexxii, Tablet, Extended Release, 36 mg — Available
- Relexxii, Tablet, Extended Release, 45 mg — Available
- Relexxii, Tablet, Extended Release, 54 mg — Available
- Relexxii, Tablet, Extended Release, 63 mg — Available
- Relexxii, Tablet, Extended Release, 72 mg — Available
Strengths and packs as listed by the regulator. Manufacturer names and product codes are not shown.
What buyers can do
- Check whether other registered presentations or strengths can be used, and ask your wholesaler about allocation.
- For hospital and tender supply, look for manufacturers that already hold an approval in your market and can increase output.
- In a critical shortage, the FDA can allow temporary importation of a version approved in a well-regulated market. That decision is made by the FDA, case by case.
- Qualify any new source as carefully as at any other time: GMP certificate, registration status and a certificate of analysis for each batch.
More: where licensed suppliers can step in during US shortages.
Controlled medicine
Supply needs valid import and manufacturing permits in both countries. Contact bd@pharmatradz.com with your licence details.
Follow this shortage
We email you when its status changes. Confirm first; unsubscribe any time.
Related shortages
For information only. Shortage status changes often; confirm with the regulator before making decisions. Brand names, where shown, are trademarks of their owners.
